Lo, Serigne N.
Smit, Amelia K.
Espinoza, David
Cust, Anne E.
Cust, Anne E.
Newson, Ainsley J.
Morton, Rachael L.
Kimlin, Michael
Keogh, Louise
Law, Matthew H.
Kirk, Judy
Dobbinson, Suzanne J.
Kanetsky, Peter A.
Mann, Graham J.
Dawkins, Hugh
Savard, Jacqueline
Dunlop, Kate
Trevena, Lyndal
Jenkins, Mark
Allen, Martin
Butow, Phyllis
Wordsworth, Sarah
Lo, Serigne N.
Low, Cynthia
Smit, Amelia
Espinoza, David
,
Funding for this research was provided by:
National Health and Medical Research Council (112822, 1147843)
The University of Sydney (Research Training Program (RTP) Stipend Scholarship and a Merit Top Up Scholarship)
Melanoma Institute Australia (Postgraduate Research Scholarship)
Article History
Received: 19 February 2020
Accepted: 25 April 2020
First Online: 30 June 2020
Ethics approval and consent to participate
: Ethical approval has been obtained from the Human Research Ethics Committee at The University of Sydney (2017/163). The study was carried out in compliance with national and state legal and regulatory requirements and according to the International Principles of Good Clinical Practice (ICHGCP). As such, all trial participants gave informed consent prior to joining the trial.
: Not applicable
: The authors declare that they have no competing interests.